Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Tazarotene - GRI Bio

Next Previous
Drug Profile

Tazarotene - GRI Bio

Alternative Names: GRI-0621; Tazarotene oral - GRI Bio

Latest Information Update: 03 Jun 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator GRI Bio
  • Class Anti-inflammatories; Antiacnes; Antifibrotics; Antipsoriatics; Esters; Hepatoprotectants; Keratolytics; Nicotinic acids; Pyrans; Pyridines; Retinoids; Small molecules
  • Mechanism of Action Natural killer T cell inhibitors; Retinoic acid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase II Idiopathic pulmonary fibrosis
  • Discontinued Liver disorders

Most Recent Events

  • 23 May 2025 Efficacy, pharmacodynamic and adverse events data from a phase IIa trial in Idiopathic pulmonary fibrosis released by GRI Bio
  • 08 May 2025 The Independent Data Monitoring Committee (IDMC) recommends to continue the phase IIa study for Idiopathic Pulmonary Fibrosis
  • 07 May 2025 Updated adverse events data from a phase IIa biomarker trial in Idiopathic pulmonary fibrosis released by GRI Bio

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top